TREATMENT OUTCOMES OF PROLONGED INDUCTION OR RE-ESCALATION DOSING OF UPADACITINIB IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE

被引：0
|
作者：
Annadurai, Vasantham
Axenfeld, Ellen
Faye, Adam S.
Axelrad, Jordan E.
机构：
来源：
GASTROENTEROLOGY | 2024年 / 166卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
Mo1859
引用
收藏
页码：S1147 / S1147
页数：1
相关论文
共 50 条
  • [21] Dosing interval and diagnosis predict infliximab levels in patients with inflammatory bowel disease on maintenance treatment
    Krajcovicova, A.
    Batovsky, M.
    Gregus, M.
    Hlista, M.
    Durina, J.
    Leskova, Z.
    Sturdik, I
    Gojdic, M.
    Jalali, Y.
    Koller, T.
    Toth, J.
    Huorka, M.
    Hlavaty, T.
    ACTA GASTRO-ENTEROLOGICA BELGICA, 2018, 81 (04) : 465 - 470
  • [22] De-escalation of Therapy in Patients with Quiescent Inflammatory Bowel Disease
    Miyatani, Yusuke
    Kobayashi, Taku
    GUT AND LIVER, 2023, 17 (02) : 181 - 189
  • [23] Predictors of Vedolizumab Dose Escalation or Cessation in Inflammatory Bowel Disease Patients
    Razvi, Mohammed A.
    Chowdhury, Reezwana
    Parian, Alyssa
    Melia, Joanna
    Truta, Brindusa
    Brant, Steve
    Dudley-Brown, Sharon
    Lazarev, Mark
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2017, 112 : S417 - S418
  • [24] Efficacy of combination vedolizumab and upadacitinib treatment in refractory inflammatory bowel disease: a case series
    Swe, Ei Phyu Phyu
    Gilmore, Robert
    Murali, Amrutha
    Etchegaray, Amirah
    Fernandes, Richard
    An, Yoon-Kyo
    Begun, Jakob
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2024, 39 : 244 - 245
  • [25] Higher Induction Propofol Dosing Decreases Induction Time for Sedation of Inflammatory Bowel Disease Patients Undergoing Elective Endoscopic Procedures
    Zhang, Daniel S.
    Stana, Roman
    Abraham, Bincy
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2019, 114 : S1590 - S1590
  • [26] HIGHER INDUCTION PROPOFOL DOSING DECREASES INDUCTION TIME FOR SEDATION OF INFLAMMATORY BOWEL DISEASE PATIENTS UNDERGOING ELECTIVE ENDOSCOPIC PROCEDURES
    Zhang, Daniel
    Stana, Roman
    Abraham, Bincy P.
    GASTROENTEROLOGY, 2020, 158 (06) : S421 - S422
  • [27] De-escalation of biological therapy in Inflammatory Bowel Disease patients following prior escalation
    Thomas, P.
    Smits, L.
    Groen, M. Te
    West, R.
    Russel, M.
    Jansen, J.
    Romkens, T.
    Hoentjen, F.
    JOURNAL OF CROHNS & COLITIS, 2021, 15 : S086 - S086
  • [28] Comparison of Upadacitinib Induction in Tofacitinib Exposed and Naive Patients With Inflammatory Bowel Disease: A Real World Multi-Center Study
    Almomen, Hisham S.
    Alomar, Ibrahim
    McMillan, Chandler
    Gaidos, Jill
    Proctor, Deborah D.
    AlMutairdi, Abdulelah
    Al-Bawardy, Badr
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2023, 118 (10): : S761 - S762
  • [29] Role of Sex in the Treatment and Clinical Outcomes of Pediatric Patients With Inflammatory Bowel Disease
    Lee, Grace J.
    Kappelman, Michael D.
    Boyle, Brendan
    Colletti, Richard B.
    King, Eileen
    Pratt, Jesse M.
    Crandall, Wallace V.
    JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION, 2012, 55 (06): : 701 - 706
  • [30] Differences in clinical course, treatment and outcomes in elderly patients with inflammatory bowel disease
    Sanagapalli, S.
    Pathirana, P. Widana
    Leong, R.
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2015, 30 : 137 - 137
12345